New VANGUARD infographic available
To introduce the VANGUARD project in easier to understand terms we have developed an infographic to explain the complex research happening in VANGUARD
New article published on Immunomodulatory Properties of Amniotic Membrane Derivatives and Their Potential in Regenerative Medicine
The VANGUARD coordinator, Ekaterine Berishvili together with Charles-Henri Wassmer have recently published a new article in Current Diabetes Reports on the Immunomodulatory Properties of Amniotic Membrane Derivatives and Their Potential in Regenerative Medicine. Purpose of Review During the last decades, the field of regenerative medicine has been rapidly evolving. Major progress has been made in […]
New research on a promising treatment against type 1 diabetes funded by the European Commission
More than 40 million individuals worldwide are affected by type 1 diabetes, which is the most common chronic disease in children and adolescents. Today’s primary treatment for diabetes is insulin therapy, which requires multiple injections every day to control a person’s blood sugar levels. This can potentially lead to chronic complications such as kidney-related issues […]
VANGUARD selected for Horizon 2020 funding
Our VANGUARD proposal to develop a new bioartificial pancreas to cure type 1 diabetes has been selected for funding by the European Commission. Under the call SC1-BHC-07-2019 Regenerative medicine: from new insights to new applications, VANGUARD has been selected as one of twelve projects to be funded. The VANGUARD project aims to deliver an Advanced […]
